Electroretinography (ERG)
J15 · Effective Jan 30, 2022
55 active Medicare policies list H35.54, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Jan 30, 2022
J9 · Effective Feb 2, 2018
JH · Effective Jan 25, 2018
JL · Effective Jan 25, 2018
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
9 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H35.54 |
|---|---|---|
| Concert Genetic Testing: Ophthalmology | Not recorded | Referenced |
| Evoked Potential Testing | Not recorded | Covered |
| Extended Ophthalmoscopy | Not recorded | Covered |
| Fluorescein Angiography | Not recorded | Covered |
| Fundus Photography | Not recorded | Covered |
| Visual Field Testing | Not recorded |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Mar 16, 2017
JK · Effective Mar 16, 2017
J5 · Effective Jul 17, 2017
J8 · Effective Jul 17, 2017
J9 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Oct 1, 2024
J9 · Effective Oct 1, 2024
National · Effective Nov 16, 2023
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2025
National · Effective May 28, 2026
National · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
J6 · Effective Apr 1, 2026
National · Effective Aug 6, 2026
National · Effective Oct 1, 2025
J5 · Effective Apr 30, 2026
JL · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
J5 · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Nov 6, 2025
| Covered |
| Policy | Effective | Status of H35.54 |
|---|---|---|
| Indocyanine Green Angiography | Mar 23, 2023 | Covered |
| Policy | Effective | Status of H35.54 |
|---|---|---|
| Gene Therapy for Ocular Conditions | Apr 15, 2026 | Covered |
| Policy | Effective | Status of H35.54 |
|---|---|---|
| Luxturna (Voretigene Neparvovec-Rzyl) | Oct 1, 2026 | Covered |